Literature DB >> 26988137

Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection: Where Do We Stand?

J U Becker1, A Chang2, V Nickeleit3, P Randhawa4, C Roufosse5.   

Abstract

The definition of Banff Borderline became ambiguous when the Banff 2005 consensus modified the lower threshold from i1t1 (10-25% interstitial inflammation with mild tubulitis) to i0t1 (0-10% interstitial inflammation with mild tubulitis). We conducted a worldwide survey among members of the Renal Pathology Society about their approach to this diagnostic category. A web-based survey was sent out to all 503 current members (153 respondents). A database search yielded which threshold for Banff i was applied in the most influential manuscripts about Borderline. Among the 139 nephropathologists using the Borderline category, 67% use the Banff 1997 definition, requiring Banff i1. Thirty-seven percent admitted to sometimes exaggerating Banff i in the presence of tubulitis, to reach a diagnosis of Borderline. Forty-eight percent were dissatisfied with the definition of Borderline. The majority of the most influential manuscripts used the 1997 definition, contrary to the current one. There is considerable dissatisfaction with Borderline, and practice in Banff i thresholds is variable. Until additional studies inform a revision, we suggest leaving it to each pathologist's discretion whether to use i0 or i1 as the minimal threshold. In order to avoid future ambiguity, a web-based synopsis of all scattered current Banff definitions and rules should be created. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  classification systems: Banff classification; clinical research/practice; guidelines; kidney transplantation/nephrology; pathology/histopathology; rejection: T cell mediated (TCMR)

Mesh:

Year:  2016        PMID: 26988137     DOI: 10.1111/ajt.13784

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  16 in total

1.  Transformation in Immunosuppression: Are We Ready for it?

Authors:  Amtul Aala; Daniel C Brennan
Journal:  J Am Soc Nephrol       Date:  2018-06-08       Impact factor: 10.121

2.  Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials.

Authors:  Jan Ulrich Becker; Daniel Seron; Marion Rabant; Candice Roufosse; Maarten Naesens
Journal:  Transpl Int       Date:  2022-05-20       Impact factor: 3.842

3.  The Outcome of Tapered Steroid Regimen When Used to Treat Acute Borderline Cellular Rejection After Kidney Transplant: A Single-Center Experience.

Authors:  Abdullah Jebrini; Ana Cecilia Farfan Ruiz; Meray Hosni; Tambi Jarmi
Journal:  J Clin Med Res       Date:  2022-09-29

4.  Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection.

Authors:  Rania El Fekih; James Hurley; Vasisht Tadigotla; Areej Alghamdi; Anand Srivastava; Christine Coticchia; John Choi; Hazim Allos; Karim Yatim; Juliano Alhaddad; Siawosh Eskandari; Philip Chu; Albana B Mihali; Isadora T Lape; Mauricio P Lima Filho; Bruno T Aoyama; Anil Chandraker; Kassem Safa; James F Markmann; Leonardo V Riella; Richard N Formica; Johan Skog; Jamil R Azzi
Journal:  J Am Soc Nephrol       Date:  2021-03-03       Impact factor: 10.121

Review 5.  Artificial intelligence and machine learning in nephropathology.

Authors:  Jan U Becker; David Mayerich; Meghana Padmanabhan; Jonathan Barratt; Angela Ernst; Peter Boor; Pietro A Cicalese; Chandra Mohan; Hien V Nguyen; Badrinath Roysam
Journal:  Kidney Int       Date:  2020-04-01       Impact factor: 10.612

6.  Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis.

Authors:  Caroline Wehmeier; Patrizia Amico; Patricia Hirt-Minkowski; Argyrios Georgalis; Gideon Höenger; Thomas Menter; Michael Mihatsch; Felix Burkhalter; Juerg Steiger; Michael Dickenmann; Helmut Hopfer; Stefan Schaub
Journal:  Transplant Direct       Date:  2017-02-09

7.  Multicolor Flow Cytometry and Cytokine Analysis Provides Enhanced Information on Kidney Transplant Biopsies.

Authors:  Kimberly A Muczynski; Nicolae Leca; Arthur E Anderson; Niamh Kieran; Susan K Anderson
Journal:  Kidney Int Rep       Date:  2018-03-03

8.  Rapid Biolayer Interferometry Measurements of Urinary CXCL9 to Detect Cellular Infiltrates Noninvasively After Kidney Transplantation.

Authors:  Ilaria Gandolfini; Cynthia Harris; Michael Abecassis; Lisa Anderson; Oriol Bestard; Giorgia Comai; Paolo Cravedi; Elena Cremaschi; J Andrew Duty; Sander Florman; John Friedewald; Gaetano La Manna; Umberto Maggiore; Thomas Moran; Giovanni Piotti; Carolina Purroy; Marta Jarque; Vinay Nair; Ron Shapiro; Jessica Reid-Adam; Peter S Heeger
Journal:  Kidney Int Rep       Date:  2017-06-21

Review 9.  Transcriptome Analysis in Renal Transplant Biopsies Not Fulfilling Rejection Criteria.

Authors:  Francesc Moreso; Joana Sellarès; María José Soler; Daniel Serón
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

10.  A Rejection Gene Expression Score in Indication and Surveillance Biopsies Is Associated with Graft Outcome.

Authors:  Betty Chamoun; Anna Caraben; Irina B Torres; Joana Sellares; Raquel Jiménez; Néstor Toapanta; Ignacio Cidraque; Alejandra Gabaldon; Manel Perelló; Ricardo Gonzalo; Francisco O'Valle; Francesc Moreso; Daniel Serón
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.